欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DK/H/1199/001
药品名称
Moxalole
活性成分
macrogol 13.12 g
Potassium chloride 46.6 mg
Sodium bicarbonate 178.5 mg
Sodium chloride 350.7 mg
剂型
Powder for oral solution
上市许可持有人
Viatris ApS Borupvang 1 DK 2750 Ballerup
参考成员国 - 产品名称
Denmark (DK)
Moxalole
互认成员国 - 产品名称
Luxembourg (LU)
Iceland (IS)
Moxalole 13,125 g/35,7 mg/178,5 mg/46,6 mg mixtúruduft, lausn
Ireland (IE)
Austria (AT)
Molaxole - Pulver zur Herstellung einer Lösung zum Einnehmen
Spain (ES)
Portugal (PT)
Poland (PL)
Hungary (HU)
MOXALOLE por belsőleges oldathoz
Cyprus (CY)
MOLAXOLE PWD FOR ORAL SOLUTION
Belgium (BE)
Netherlands (NL)
United Kingdom (Northern Ireland) (XI)
Italy (IT)
Sweden (SE)
Norway (NO)
Finland (FI)
许可日期
2008/06/12
最近更新日期
2024/10/24
药物ATC编码
A06AD65 macrogol, combinations
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Non Prescription (including OTC)
附件文件下载
Final PL
|
common_pl_clean
Date of last change:2024/09/06
Final SPC
|
common_smpc_clean
Date of last change:2024/09/06
PubAR
|
Final PAR Moxalole DK_H_1199
Date of last change:2024/09/06
Final Labelling
|
Moxalole common_outer_1
Date of last change:2024/09/06
Final Product Information
|
Product information Moxalole DK_H_1199
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase